Search Results 131-140 of 15435 for infliximab

  1. Ustekinumab (injection route) - Side effects & dosage - Mayo Clinic

    Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Infliximab; Influenza Virus Vaccine, Live; Measles Virus Vaccine, Live; Mumps Virus ...

  2. Patient Resources - Mayo Clinic Research

    View patient resources recommended by the Immuno-Epigenetics Lab led by William A. Faubion Jr., M.D., at Mayo Clinic's campus in Minnesota.

  3. A Study of the Effectiveness of Methotrexate as Initial Treatment and Maintenance of a Steroid Free Remission in Ulcerative Colitis - Mayo Clinic

    ... (infliximab, adalimumab, golimumab) in the past; Primary failure or loss of response to vedolizumab in the past; Intolerance/failure of azathioprine/6-MP ...

  4. Natalizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Infliximab; Vedolizumab. Other Interactions. Certain medicines should not be used at or around the time of eating food or eating certain types of food since ...

  5. 9-11 Firefighter is Mayo Clinic Doctor

    The fireman you're about to meet saw firsthand the destruction on 9/11. At the time he was also a medical student, and today his experience continues to ...

  6. Insights into IBD genetics - Mayo Clinic

    Share · Tweet. See also. Abdominal aortic aneurysm · Acne · Actinic keratosis · Atrial septal defect (ASD) · Autoimmune pancreatitis · Back pain ...

  7. A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Active Crohn's Disease - Mayo Clinic

    ... infliximab, adalimumab, certolizumab, or vedolizumab). Exclusion Criteria: • The presence of any of the following will exclude a subject from enrollment ...

  8. Why Choose Mayo Clinic for Cancer Treatment

    The first thing to do when a patient is diagnosed is I tell that patient, this is a scary moment. We understand that. Take a deep breath. As you come to see me ...

  9. A Study to Assess the Effectiveness and Safety of Golimumab in Pediatric Participants With Moderately-to-Severely Active Ulcerative Colitis - Mayo Clinic

    Contraindications to the use of golimumab or infliximab or anti-tumor necrosis factor (TNF-alpha) therapy per local prescribing information. Participating ...

  10. Examining the clinical presentation and imaging characteristics of cryptogenic multifocal ulcerous stenosing enteritis

    ... infliximab. Recurrence to medical therapy (median of four months after treatment) occurred in six (85.7%) patients. Surgery for refractory intestinal ...